USA After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the organization’s 2019 USD 62 billion acquisition of US rare disease player Shire, Ramona Sequeira was appointed president of global portfolio commercialization and a member of Takeda’s global executive team in April 2020. In conversation with…
Switzerland PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in Switzerland today and their strategies for success in one of the world’s most innovative nations. Henrik Asmussen, General Manager, Amgen Switzerland Danish national Henrik Asmussen, head of Amgen Switzerland since 2017, outlined the…
Talent COVID-19 has necessitated enormous shifts in the way we live, work, and communicate with each other. Nowhere is this more apparent professionally than for those starting a new job. Here, we highlight four recent appointees to new roles in pharma companies across Europe and the USA and how they have…
Switzerland While Switzerland has Europe’s second-highest proportion of women in the workforce, it trails global standards on gender diversity in boardrooms and in management positions. However, this situation is changing and two of Switzerland’s most important pharma affiliates are at the forefront of a new wave of diverse Swiss leadership teams.…
Norway Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark, Norway nevertheless has excellent credentials as a pharmaceutical hub, with a top notch universal healthcare system, immaculate patient data registries, and high calibre research – especially in oncology – being carried out…
USA The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish outfit Lundbeck – explain their vital role leading operations in the world’s most innovative and lucrative pharma market, translating global cultures to a US reality, and the challenges of attracting and retaining…
Asia-Pacific Robert Hall of Hong Kong-based executive recruitment specialist Ardent Search highlights the key traits and experiences that Asian biotech and medtech firms considering an initial public offering (IPO) should look for in a chief financial officer (CFO). Hiring an experienced healthtech CFO can be challenging, with demand exceeding supply.…
Switzerland Urs Vögeli, managing director for Janssen Switzerland, outlines the importance of the Swiss operations to Janssen, his interesting career journey, Janssen’s commitment to bringing transformational medical innovations to Swiss patients, as well as his perspectives on talent development within the industry. Switzerland is very open to innovative products, and…
Opinion Robert Hall of Ardent Search, an executive search boutique specialised in the life sciences and healthcare sectors, highlights the five key points for recruiters and pharma companies to consider when hiring market access professionals to work in Asia. Whether it is an established or a developing market, access is…
Pharma Faces Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In addition to their R&D centre and a pharma production plant in Beerse, Janssen also has a chemical production plant in Geel, a Clinical Pharmacology Unit in Merksem, and a Phase I research institute in Antwerp…
Sanofi With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe as the new head of its vaccines business unit, Sanofi Pasteur, on June 15th 2020. Under the watch of CEO Paul Hudson, appointed at the end of 2019, Sanofi has initiated…
Talent A new report by Novartis looks at how leading talent in the technology industry is increasingly looking to bring their skillsets into the healthcare and life sciences industries against the backdrop of the fight against COVID-19. Top tech talent sees a myriad of opportunities to leverage its knowledge in…
See our Cookie Privacy Policy Here